Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade · PMID 42321916
View analysis →A grade · PMID 42372741
View analysis →A grade · PMID 42382416
View analysis →A grade · PMID 42150584
View analysis →A grade · PMID 42296977
View analysis →A grade · PMID 42032072
View analysis →A grade · PMID 42217458
View analysis →A grade · PMID 42349316
View analysis →A grade · PMID 42234929
View analysis →A grade · PMID 41420350
View analysis →A grade · PMID 42284089
View analysis →A grade · PMID 42276189
View analysis →This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 22.0; sample size: 40.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 54.2; sample size: 20.0; recency: 100.0; abstract quality: 40.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 51.7; sample size: 20.0; recency: 80.0; abstract quality: 65.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 24.1; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.3/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 69.1; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 24.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.3/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 69.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.3/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 69.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 24.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 24.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.2/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 16.0; sample size: 50.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.2/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 16.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.2/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 16.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.2/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 23.5; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.2/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 16.0; sample size: 50.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.2/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 23.5; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.2/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 16.0; sample size: 50.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.2/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 23.5; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.2/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 41.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 60.2/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 23.5; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
